Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1420_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
10 Мб
Скачать
☆
208
Fig. 10.5 Free indication of gracilis
sphincter; the second is to nd the boundary of the interval. Generally, there will be no bleeding. (3) The free tissue ap should be paid attention to so as to protect the blood supply of the tissue, generally starting from the top in the separation process, carefully identifying the tissue supply blood vessels to protect. Freely isolate the tissue before repairing the stula, thus ensuring that there is a certain period of time to observe the blood supply of the tissue, and at the same time ensure that the free tissue has sufcient length, and the method of measuring the length by pulling and separating the tissue can be adopted. It is also necessary to ensure that the tissue has sufcient thickness so that the blood supply can be effectively ensured and that the thickness of the interval can be made standard. (4) When the same tissue is isolated, care should be taken not to leave dead space; during the suturing process, the blood supply to the original end of the tissue cannot be blocked to avoid tissue necrosis. (5) When closing the perineal body, pay attention to the drainage. You can use a rubber piece to pull out from the incision. Generally, the drainage piece can be removed after 48 h. (6) After the operation, enteral nutrition is generally used to control defecation for 1 week, so it is completely unnecessary to make a preventive stoma.
R. Shi and F. Liu
mucosa (Crohn’s disease with proctitis), the injection of sclerosing agent will cause the rectal mucosa to be hardened. Transvaginal valvular valve repair or stula resection combined with stratied suture can also achieve good results.
Surgical methods: (1) good exposure of the posterior wall of the vagina, the surgeon should stick a nger into the anus to jack up the mouth. Dilute adrenaline uid is injected under the vagi­nal mucosa around the stula. A circular incision should be made 0.5cm from the edge of the s­tula with a curved scalpel blade, deep to the vagi­nal fascia. (2) The vaginal margin of the incision is to be pulled with a tissue forceps, and the vagi­nal mucosa and the rectal wall are to be centri­fuged about 2cm around the mouth with a curved blade. The vaginal mucosa of the mouth should be slightly separated from the center by about 2mm, and the scar of the mouth should not be removed. (3) The suture is to be sutured along the edge of the mouth with a No. 1 silk thread, and the suture should not pass through the rectal mucosa. The larger mouth (>2cm) will be inter­rupted by suture. (4) The vaginal submucosal connective tissue should be sutured with a No. 1 silk thread to reinforce the front of the stula. (5) The vaginal mucosa should be sutured intermit­tently with a 3-0 absorbable line. The vagina is to be lled with an iodov gauze roll.
Tang Jie etal. used this procedure to treat 13 patients with rectal vaginal stula. The postoper­ative vaginal defecation symptoms disappeared, and patients were discharged. The hospital stay was 11–16 days, with a median of 12 days. All patients were followed up for 0.5–7 years, with an average of 2.5 years. All 13 patients were able to defecate normally. There was no venting and defecation in the vagina. The rectal examination and vaginal speculum were well examined. The rectal vaginal stula healed well. There was no recurrence of rectal vaginal stula. No symptoms such as vaginal stricture occurred.
Transvaginal Repair
Transvaginal surgery is used by most gynecolo­gists and has certain advantages in some special cases. For patients who have failed multiple rec­tal valvuloplasty or patients with unhealthy rectal
Transperitoneal Repair
Transabdominal repair is often used for vaginal bladder stula or vaginal colon hernia repair and rectal vaginal stula after rectal cancer surgery. Laparoscopic surgery is sometimes used, and
10 Diagnosis andTreatment ofSpecial Anal Fistula
209
laparoscopic direct vision helps to identify the structure and facilitate separation.
Wang Gangcheng etal. reported the method of colonic transanal extraction combined with pedicled omental packing. The specic methods are as follows: (1) the patient takes the lithotomy position. After the anesthesia is successful, the perineal group of surgeons expand the anus, revealing the ushing rectal anastomosis, vagi­nal and rectal vaginal stula. Then, they should disinfect and remove the ulcerated tissue around the vaginal stula. (2) Open the abdominal cav­ity along the original incision and extend the incision upward to expose the greater omentum, transverse colon, and left colon. Free the descending colonic peritoneum, spleen colon ligament, gastric colon ligament, broken submu­cosal vein, and descending colonic rst-class ovoid arch trafc branch, so that the left colon is completely free from the middle of the trans­verse colon, and pay attention to protect the arteries and veins in the colon. (3) Separate the pelvic adhesions and free the colon above the anastomosis. Care should be taken to protect the bilateral ureters and mesenteric vessels and com­pletely detach the pelvic intestines. (4) The intestinal clamp should block the proximal intes­tinal tube, prevent the intestinal contents from being contaminated and contaminate the abdom­inal pelvic cavity, and the intestinal tube is freed from the anastomosis to the lower rectum. The anastomosis is 3.0cm below the rectum, and the stump stops bleeding. (5) Again, the rectal stump, vaginal and rectal vaginal stula should be rinsed and disinfected. (6) The left colon is to be pulled out of the body through the rectal stump and the anus and is xed to the skin. When xing the intestine, avoid suturing the mesen­teric vessels and preventing intestinal necrosis. (7) Free the omentum. The large omentum with the right aortic vein of the gastric retina is com­pletely freed from the left aortic vein of the gas­tric retina to the root from the abdomen and avascular zone of the stomach. (8) Isolation and repair. The pedicled omentum is passed through the transverse colon and the small mesenteric avascular zone (vertical distance) to the pelvic
oor, and the omentum is placed under the vagi­nal opening. The perineal group should use the absorbable line to suture the vaginal stula together with the underlying omentum while avoiding the omental inclusions in the vaginal incision so as not to affect the healing of the s­tula. (9) After 3–4 weeks, after the adhesion between the colon and the anus is rm, remove the extraintestinal tube outside the anus.
Wang Gangcheng and others treated 12 patients with this method. The operation was suc­cessful, and the median operation time was 95 min. The median amount of bleeding was 250ml. Eight patients recovered well after opera­tion, and the anus was drained from 5 to 8 days. Among the other four patients, two had pulmo­nary infection and two had incisional fat lique­faction. Eight to 12 days after surgery, the anus was drained. Nine of the 12 patients underwent vaginal examination at 3 weeks post-surgery. The posterior vaginal wall was dense, with no empti­ness, and a pelvic CT examination was carried out. There was no uid in the vaginal rectal space, and the intestine was removed. In the other three cases, vaginal examination was performed 3 weeks after operation. The posterior vaginal wall was loose and emptied. The posterior wall of the vagina and the omentum were not adhered tightly. After 6 weeks under a pelvic CT examination, there was no effusion in the vaginal rectal space. The limp was removed from the intestine. All 12 patients were followed up for 3 months. Among them, ve patients developed anal stenosis 1 month after operation and were cured by inter­mittent anal sphincter. There was no intestinal retraction and vaginal discharge of intestinal con­tents or venting, which were all successfully repaired. Barium enema indicates that the rectal vaginal stula disappears.
Some literature reports the use of sleeve seg­mental resection of the rectal intestine and suture of the stula, the proximal intestine, and anal dentate line anastomosis for the treatment of rectal vaginal stula. However, this method is complicated to operate and may affect the func­tion of the anal sphincter, so it has few clinical applications.
210
R. Shi and F. Liu
Kraske Posterior Approach
In 2009, Schouten etal. reported the use of the Kraske posterior approach in the treatment of eight patients with recurrent low-grade rectal vaginal stula, through the sleeve resection of the rectum, proximal rectum, and dentate line direct anastomosis, and achieved a better effect. The patient takes the folding position, corresponding to the left end of the tailbone area from the junc­tion of the appendix to the anal external sphincter for longitudinal incision, the distal end of the tail­bone is removed, the pelvic oor is exposed, and the lower part of the posterior wall of the rectum is cut longitudinally to expose the anterior wall of the rectum. The truncated section of the rectum is cut to ensure a sufcient range of resection. Identify the enlarged stula, remove the scar tis­sue, layer the suture of the vaginal and rectal muscle layer, open the drainage of the vaginal mucosa, pull the proximal rectum and the dentate line to manually suture the anastomosis, close the pelvic oor peritoneum, drain the wound, and close the layer incision.
The method reported by Qiu Huizhong is that the patient takes the prone position, the hips are raised as much as possible, and the sides of the buttocks are stretched to the sides with a wide tape to expose the perineum as much as possible. From the appendix joint, make a midline incision to the anal margin, about 12cm long, and cut the skin and subcutaneous layer. Determining whether to remove the tailbone should be done according to the distance from the anal margin of the mouth. If the distance from the anal margin is greater than 6cm, the tailbone should be removed; otherwise, it may not be removed. The anal exter­nal sphincter and the puborectalis muscle were cut off in groups, and the posterior wall of the rectum should be cut upward from the anal mar­gin until the stula of the anterior wall of the rec­tum is revealed. After revealing the stula, rst remove the scar around the stula, then lift the rectal wall at the edge of the stula to carefully dissect the inammatory adhesion between the rectum and the vaginal wall. After separation, the rectal wall and the vaginal wall are free. The edge is preferably greater than 2–3cm to minimize the tension during stitching. Then, the vaginal wall
and the rectal wall of the stula should be sutured intermittently. Finally, the incision on the poste­rior wall of the rectum is to be sutured, and the anal external sphincters should be cut to repair the suture. If the tailbone is removed during the operation, a drainage is placed in the coccyx at the end of the operation. Qiu used this method to treat 23 cases of rectal vaginal stula, and 3 cases of wound infection occurred after operation. The wounds healed after a dressing change. The 23 patients were all hospitalized 8.0 ± 1.0 days. After being followed up for more than 3 months, some were admitted to the hospital again. After examination, 19 cases (82.6%) healed, and 4 cases (17.4%, including one case of loss of fol­low- up) were not healed. All patients were fol­lowed up for 3 months to 7 years with an average of 20.8 months. The 23 patients had no postop­erative anal dysfunction except for possibly one who did not follow up. Nineteen patients who were successfully repaired had no recurrence of rectal vaginal stula after colostomy.
The author believes that this method is slightly complicated, traumatic, technically demanding, easy to infect, and needs a high level of attention.
By Perineal Incisional Repair (Musset)
Perineal rectal incision through the perineal approach has a unique advantage in the treatment of middle and lower rectal vaginal stula with anal sphincter injury. The main point of the peri­neal rectal stula is to convert the recto-vaginal stula into a grade IV perineal laceration and then suture the laceration layer by layer. The big­gest advantage of this procedure is that the surgi­cal eld is wide, the surgical path is shallow and straight, and it can fully enter the stula and sphincter defects so as to carry out adequate sphincter folding and perineal reconstruction. However, incision of the anal sphincter has the risk of postoperative anal incontinence.
Musset uses a surgical method that directly cuts the perineal body from the rectum and the vagina to the rectal vaginal stula, sutures the rectal wall, the levator ani muscle and the exter­nal sphincter, and nally sutures the vaginal wall. The main points of the procedure are as follows:
10 Diagnosis andTreatment ofSpecial Anal Fistula
211
fully revealing the stula, the morphological changes are made to the full layer of the vaginal body, and the skin, the subcutaneous, the lower sphincter of the stula, and the stula are directly connected (Fig. 10.6). After the infection and necrotic tissue are removed, the vagina is sepa­rated sharply. The interstitial tissue between the posterior wall and the anterior wall of the rectum is freely distributed upward to the proximal side of the stula by 2–3 cm and is released to the lower edge of the external sphincter and levator ani muscle. After complete hemostasis, the upper layer of the rectal wall is to be rst sutured with the strong absorption of Weishengwei 4.0, and then the levator ani muscles and the external sphincter muscles are to be sutured with absorb­able lines. The suture of the muscles is not suit­able for knotting. Finally, the vaginal full layer and perineal incision are sutured (Fig. 10.7). Antibiotics should be used for 5 days to prevent infection. After fasting for 3 days, patients were fed on the fourth day, and solid food was taken after 1 week. After the anal canal was placed for 3 days, the catheter was kept for 1 week. Avoid premature defecation, and take a bath with 1:5000 potassium permanganate solution after defecation.
According to foreign reports, the success rate of Musset in the treatment of rectal vaginal stula is 87–100%. Shen Zhen etal. used this method to treat 20 cases of rectal vaginal stula. All patients underwent surgery successfully. The operation
time of the whole group was 30–50 min. Six patients had perineal incision redness and puru­lent exudation. Healing and physiotherapy healed well; hospitalization time was 10–15 (average
12.1) days. All patients were followed up for out­patient and telephone follow-up, with an average follow-up of 7.0 ± 2.6 months; no recurrence occurred.
In 2011, Hull et al. retrospectively analyzed 87 patients with rectal vaginal stula and found that the success rate of perineal rectal incision and rectal valvuloplasty was similar, but postop­erative sexual function and control in patients with perineal rectal incision was signicantly improved.
Transanal Endoscopic Minimally Invasive (TEM) Surgery
Transanal endoscopic minimally invasive (TEM) surgery is a new method for repairing rectal vagi­nal stula. It has the advantages of being mini­mally invasive, having clear visual eld and accurate mouth recognition. The disadvantage is that it is difcult to conduct the operation and its application range is limited. It is limited to the rectal mucosal ap. Covering the endoscopic operation of the repair, some of this still needs to be done manually.
Synthetic Materials Repair Spells
Since 2004, more and more research groups have reported the use of biological patches in recto-
Fig. 10.6 Transperineal repair of congenital rectovaginal stula
Fig. 10.7 After transperineal repair of congenital recto­vaginal stula
212
R. Shi and F. Liu
vaginal stulas. The decellularized dermal graft patch retains the biological scaffold mainly com­posed of collagen and extracellular matrix by removing the antigen component. After being implanted into the body, due to the reticular framework structure, the host cells can be induced and promoted to grow on the scaffold, and the degradation products of the host are absorbed by the normal tissues, thereby completing the regen­erative reconstruction of the defect tissue. In 2006, Shelton and Welton reported that the use of acellular dermal patch for reoperation of two patients with recurrent rectal vaginal stula was successful. Other repair methods, such as brin glue closure and Surgisis Biodsign stula, have been gradually applied to the treatment of rectal vaginal stula since the 1990s, but due to the lim­ited number of studies, the failure rate is high, and currently, it is almost not used as the rst line of treatment for rectovaginal stula.
10.3.4.2 Preoperative Management
Preoperative bowel preparation: 3 days before surgery, patients should halt the intake of food, oral laxatives, and no slag diet 1 day before sur­gery. Oral parenteral antibiotics should be taken to keep the intestinal tract relatively clean after surgery, delaying postoperative formation of feces, and ensuring there is no high pressure and high tension in the early rectal area.
Postoperative management: patients should stay in bed after surgery, indwelling catheteriza­tion, and maintaining a slag-free diet for about 1 week to avoid increasing the traction in the operating area. It is recommended to inject intravenous metronidazole and cephalosporin antibiotics on the rst day before surgery and change oral antibiotics or antibiotics after sur­gery. Avoid constipation and sexual life within 3 months after surgery.
10.3.4.3 Others
There has been a great deal of controversy about the role of proximal colostomy in the repair of rectal vaginal stula. In 2016, Lambertz et al. found through retrospective studies that proximal colostomy did not help to improve the recurrence rate after rectal vaginal hernia repair, which coin-
cided with the views of Jones et al. However, Corte etal. performed a total of 286 surgical pro­cedures on 79 patients with rectal vaginal stula and found that temporary fecal diversion surgery signicantly improved the success rate of repair.
Peng Hui and others believe that for the lower rectal vaginal stula with good general condition and small wound inammatory reaction, the fecal diversion ostomy should not be routinely per­formed. However, if the diameter of the stula is larger and the position is higher, multiple repair failures have occurred, and for rectal vaginal s­tulas with difcult to control inammatory responses, or those with poor general tumors, radiotherapy, and Crohn’s disease rectal vaginal stula, the suggestion is a proximal colostomy to control infection. Denitive repair surgery is per­formed on the basis of nutritional support.
The stoma is usually performed after clearing when the rectal vaginal stula has healed for 3 months. There are also studies that do not make a stoma by extending the fasting time, total paren­teral nutrition support, etc.

10.4 Tuberculous Anal Fistula

The rectal anus is prone to getting stulas. Before the discovery of modern anti-tuberculosis drugs, most anal stulas were caused by tuberculous. Since the widespread use of anti-tuberculosis drugs in recent times, tuberculous stulas have been greatly reduced. At present, tuberculous anal stula accounts for 3–4% of extrapulmonary tuberculosis, which is the sixth most common infection point of extrapulmonary tuberculosis. The disease is more common in men and is often associated with tuber­culosis. At present, it is relatively rare in clinical practice, and there are many atypical cases that are easy to misdiagnose and mistreat.

10.4.1 Cause

Tuberculous anal stula is a specic infection formed by Mycobacterium tuberculosis around the anus. The traditional classication of tubercu-
10 Diagnosis andTreatment ofSpecial Anal Fistula
213
losis is a type of skin cavity. It is thought to be a tuberculosis lesion inside the body or tissue, or ingested with bacteria or sputum, so that Mycobacterium tuberculosis is brought to the skin near the cavity through the natural cavity to form an infection. Mycobacterium tuberculosis can also enter the bloodstream and reach the anus through blood circulation, causing tuberculosis. Skin and mucosal trauma can also be followed by primary inoculation of mycobacteria.
Chinese medicine believes that the occur­rence of tuberculous anal stula forms mostly due to patients’ diet, heat and heat endogenous, damage to the lung and spleen, blockage of the large intestine or anus, or due to anal damage, meridian obstruction, or blood stasis. The syn­drome type is mostly yin deciency internal heat, or both humid and hot blockage and lack of blood owing smoothly.

10.4.2 Clinical Manifestations

The typical local manifestations of tuberculous anal stula are special. Redness and swelling in the attack period are not obvious, local pain is not severe, and ulceration is long-term. Pus is the main symptom, it is more dilute, and the mouth is not closed for a long time. Skin lesions begin with brown-red papules, which can then develop ulcerative plaques called tuberculous sputum. There are many external mouths, irregular, with large openings, fusiform shape, often curled at the edges or subcutaneously, and the surrounding skin is dark. The granulation tissue is pale and swollen and slightly ooded. There are many branches of the stula, pus is thin, the color is yellowish, or there are rice water and cheese-like secretions. The wall of the tube is soft, the lumen is large, and the inner port is larger than the com­mon stula. Most tuberculous anal stulas do not follow Goodsall’s laws. Local lymph nodes often have swelling. If it is not diagnosed as tubercu­lous anal stula before surgery, the wound will not heal for a long time after surgery.
Typical tuberculous anal stula patients often have more or less systemic manifestations of Mycobacterium tuberculosis infection, such as
long-term persistent low fever, sometimes even high fever, night sweats, cough, hemoptysis, chest pain, fatigue, irritability, anorexia, etc.
At present, atypical tuberculous anal stula is more common, and its symptoms are similar to those of nontuberculous abscess or anal stula. Douglas’s research shows that most patients with tuberculous anal stula do not have convincing symptoms of systemic tuberculosis. Because there is no systemic tuberculosis, missed diagno­sis and misdiagnosis are likely to occur.
According to Wang Zhigang and Lu Weijian, the current clinical features of tuberculous anal stula are the following: (1) patients are more likely to be young and middle-aged men, and they occur more often because of perianal abscess, pain, or stool with blood. (2) The symp­toms of the respiratory system and tuberculosis poisoning are often not obvious. Patients can often nd tuberculosis after a chest X-ray exami­nation. (3) Laboratory examination: the positive rate of acid-fast staining of sputum and purulent secretions is higher. (4) There is a long history of misdiagnosis. Because the anal stula does not heal, tuberculosis is usually found only after repeated diagnosis. (5) Compared with the clini­cal symptoms of other nonspecic infectious anal stulas, tuberculous perianal abscess is softer in texture, but the tenderness is not obvious, and there is a sense of uctuation. After the formation of anal stula, there is often a depression in the outer mouth, which is a cylinder mouth, no indu­ration, irregular, not fresh, easy to bleed, and at the same time, the surrounding skin is often dark purple, granulation tissue is grayish-white, and it can be seen as cheese-like necrosis. The pus is usually thin, is pale yellow in color, and quite like the water after washing rice.
10.4.3 Inspection andDiagnosis
The early diagnosis and correct treatment of tuberculous anal stula are difcult, and doctors need a certain level of experience and high vigi­lance against this disease. When the anal stula is not healed for a long time, a biopsy should be performed and pathological examination and
214
R. Shi and F. Liu
bacterial culture should be performed to exclude tuberculosis infection.
Tuberculous anal stula needs to rely on biopsy and tuberculosis culture to diagnose. Biopsy tissue acid-fast staining (Ziehl–Nielsen staining) found that mycobacteria, or positive guinea pig vaccination, or skin-like pathologi­cally visible caseous necrotic granuloma, all con­tribute to the diagnosis of tuberculosis. Since the culture takes 4 weeks, some new methods are more useful such as PCR amplication to detect bacterial DNA, which takes only 48h.
However, many times, sputum secretions were taken for acid-fast staining, and no mycobacteria were found. The chest X-ray, PPD test, and eryth­rocyte sedimentation test were also found to be normal. When this happens, the stula tissue is used for disease detection, and Xerox staining to nd acid-fast bacilli is an effective diagnostic method. Pathological examination can conrm the diagnosis. However, it is not easy to obtain tuberculosis lesions in brosis, and small lesions of varying depths and typical tuberculosis lesions can only be found inlocal lymph nodes.
Colonoscopy does not help the diagnosis of tuberculosis because the morphology of the mucosa and mucosal biopsy lack specic perfor­mance, making it difcult to rule out other lesions. However, if the biopsy pathology has tuberculosis, it can be diagnosed.
Patients with tuberculous anal stula must be diagnosed with or without tuberculosis. The methods for diagnosing tuberculosis include the following: (1) sputum smear for tuberculosis: it is simple, fast, and inexpensive, and the results are available on the same day, but the type of bacteria cannot be distinguished; the sensitivity is low, usually 5000–10,000 and the bacteria/ml can obtain positive results; the specicity is poor, and various acid-fast bacilli can be colored, and fur­ther tests are needed to determine whether it is tuberculosis. (2) Tuberculosis culture of sputum is a reliable method for identifying live bacteria and is known as the “gold standard.” The short­coming is that it takes a long time, it takes several days to 2 weeks to report results, and the sensitiv­ity is low. Only about 80% of the smear-positive specimens are culture-positive; the specicity is
poor, and various mycobacteria can grow, and a drug sensitivity test needs to be combined. Identication of mycobacterial species can deter­mine whether it is tuberculosis. (3) Mycobacterium species identication: based on the physicochemical properties of different mycobacteria, mainly biochemical methods. Different strains of mycobacteria can be accu­rately identied, but the operation is complicated, and the drugs used in individual tests have certain risks. (4) Chest X-ray or video and CT examina­tion. Tuberculosis of the lungs can often be found. (5) Tuberculin skin test positive is more common, has a certain reference signicance, but there are also false-positive or false-negative cases. (6) T-SPOT test: there are specic effector T lymphocytes in the infected patients, and the effector T lymphocytes secrete various cytokines (IFN-γ) when stimulated by the antigen again. Therefore, examination of effector T lympho­cytes can be used for the diagnosis of tuberculo­sis or potentially infected persons with tuberculosis. That is to say, the cytokine secreted by the cells in the culture is captured by the anti­body and expressed by enzyme-linked spot color development. The T-SPOT assay is a C-interferon release assay that uses TLR to detect T cells that respond to 6 kD early secreted target antigens and 10kD cultured lter protein–peptide pools to diagnose tuberculosis infection. It has high sensi­tivity and specicity and is not affected by the immunity of the body and BCG vaccination. According to US FDA data, its sensitivity is
95.6%, and the sensitivity of domestic clinical data report is 95.3%. There is a high rate of detec­tion in patients with extrapulmonary tuberculo­sis. A negative result suggests that there are no effector T cells specic for Mycobacterium tuberculosis in the patient. Negative results may be related to different stages of infection, a small number of patients with immune system dysfunc­tion or disease, and abnormal operation of the experiment. Negative results suggest that there are effector T cells specic to Mycobacterium tuberculosis in the patient, and the patient has tuberculosis infection. However, whether it is active tuberculosis, it is necessary to combine clinical symptoms and other examinations and
10 Diagnosis andTreatment ofSpecial Anal Fistula
215
examination indicators to comprehensively judge the situation. When M. kansasli, M. szulgai, M. marinum (sea), and M. gordonae (Gordon) are infected with four environmental mycobacteria, the T-SPOT test also has certain false positives. This test method is used by more and more researchers to identify active tuberculosis and latent tuberculosis infections and to predict the risk of tuberculosis.
Tuberculous anal stula needs to be differenti­ated from Crohn’s disease, actinomycosis, anal stula, gelatinous carcinoma, sarcoidosis, and other skin diseases. It should be noted that tuber­culosis is rarely considered in the differential diagnosis of perianal ulcers. Some tuberculous anal stulas were initially diagnosed as Crohn’s disease, so attention should paid to the medical history and to whether the patients have had con­tact history such as epidemic areas. In the absence of evidence of tuberculosis, at least for Crohn’s disease, the stula should not be easily diagnosed and treated, but a tuberculin test and long-lasting ulcer tissue should be rst cultured.

10.4.4 Treatment

Once tuberculous anal stula is diagnosed, regu­lar anti-tuberculosis treatment should be done promptly. After anti-tuberculosis treatment for a period of time, if necessary, surgery should be performed. Surgical treatment should be per­formed after the local and systemic symptoms have subsided, and the symptoms will continue to alleviate for several months. If the incision does not heal for a long time after surgery, the tubercu­lous anal stula should be diagnosed after an examination, and anti-tuberculosis drugs should be treated as soon as possible. Local anti­tuberculosis drugs can be used to help the sore surface healing.
10.4.4.1 Anti-tuberculosis Treatment
The Principle ofTreatment
The key to anti-tuberculosis treatment is to con­trol systemic and local tubercle bacilli infection. A reasonable and regular chemotherapy regimen
must have two or more bactericidal drugs, a rea­sonable dose, a scientic method of use, a suf­cient course of treatment, and a standard and early medication to cure tuberculosis. In order to thoroughly treat tuberculosis, we must follow the above ve principles: early, joint, appropriate, standardized, and full-course. We must ensure that the rule must be ruled out, and the rule must be thorough. The lack of any of the above compo­nents can lead to treatment failure.
1. Early Early treatment can help the lesions absorb
and dissipate without leaving traces.
2. Combination Patients with initial treatment or re-
treatment should be combined with drugs, and the cause of clinical failure is often refractory to single medication. Combination therapy must be combined with two or more drugs to prevent or delay the development of drug resistance and can improve the sterilization effect. There are both intracellular bacteri­cidal drugs and extracellular bactericidal drugs, as well as bactericidal drugs suitable for acidic environments so that the chemo­therapy regimen achieves the best effect. This can also shorten the course of treatment and reduce unnecessary waste of resources.
3. Moderate Be sure to use appropriate doses under the
guidance of a specialist. If the dose is too large, the blood drug concentration is too high, and it may cause a large toxic side reac­tion in the digestive system, nervous system, or urinary system, especially to the liver and lung. When the dose is insufcient, the blood concentration is low, and the antibacterial effect is not achieved. Sterilization is there­fore not achieved, and it is easy to develop drug resistance.
4. Specication Because tuberculosis is a stubborn bacteria
with a long split cycle, slow growth, and reproduction, it is difcult to kill. In treat­ment, the medication must be standardized. If the medication is improper, symptom relief will not be achieved, which will inevitably
216
R. Shi and F. Liu
lead to the occurrence of drug resistance, resulting in treatment failure, and it will be more difcult to treat in the future. Therefore, medication must be strictly regulated.
5. Full course One course of treatment is for 3 months.
The full course of treatment is 1 year or 1 and a half years. Short-term treatment should not be less than 6 or 10 months.
It should be noted that the drug resistance of tuberculosis has increased year by year. The WHO 2008 report showed that the global tuber­culosis total resistance rate was 20%, and the multidrug resistance rate was 5.3%. China is one of 27 countries with high MDR-TB and high­drug- resistant tuberculosis. The treatment of severe drug-resistant tuberculosis is more com­plicated. At present, in addition to standard treat­ment, chemotherapy, intervention, and immune treatment have been gradually adopted.
Traditional Chinese medicine plays an impor­tant role in the treatment of tuberculosis. Chinese medicine treatment of tuberculosis is mainly aimed at the body’s own resistance, by strength­ening the body’s immune function and resistance, to achieve the role of inhibition of tuberculosis. At the same time, in the treatment of tuberculo­sis, traditional Chinese medicine can also inhibit and reduce the side effects of western medicine on the stomach, liver, and kidney.
Medication Plan
This is generally divided into the intensive treat­ment phase (intensive phase) and consolidation therapy phase (consolidation phase). Standard in the intensive chemotherapy regimen is four drugs in combination for 2 months, while that in the consolidation phase is two or three drugs in com­bination for 4 months.
1. Recommended treatment plan for initial treat-
ment of dysentery and/or vaginal tuberculosis
2HRZE/4HR (H: isoniazid, R: rifampicin,
Z: pyrazinamide, E: ethambutol).
The intensive phase should be treated with
the HRZE regimen for 2 months and contin-
ued with the HR regimen for 4 months. The course of treatment is generally 6 months. For patients with severe disease or comorbidities that affect prognosis, the course of treatment may be extended appropriately.
2. Recommended treatment plan for retreatment of tuberculosis
2SHRZE/6HRE or 3HRZE/6HRE (S: streptomycin, H: isoniazid, R: rifampicin, Z: pyrazinamide, E: ethambutol).
The intensive phase should be treated with the SHRZE regimen for 2 months, and the duration of treatment with the HRE regimen for 6 months, or the intensive phase with the HRZE regimen for 3 months, and the extended phase with the HRE regimen for 6 months. After obtaining the results of the patient’s anti-tuberculosis drug sensitivity test, a rea­sonable treatment plan should be selected according to the drug resistance spectrum and the history of previous treatment. The course of treatment is generally 8 months. For patients with severe disease or comorbidities that affect prognosis, the course of treatment may be extended appropriately.
3. Recommended treatment plan for multidrug­resistant tuberculosis
6 Z Am(Km,Cm)Lfx(Mfx)Cs (PAS)Pto/18 Z Lfx(Mfx)Cs(PAS )Pto Scheme (Lfx: levo­oxacin, Mfx: moxioxacin, Am: amikacin, Km: kanamycin, Cm: capreomycin, Pto: pro­thionamide, PAS: p-aminosalicylic acid, Cs: cycloserine).
The Z Am (Km, Cm) Lfx (Mfx) Cs (PAS) Pto regimen should be used for 6 months dur­ing the boost period and continued for 18 months using the Z Lfx (Mfx) Cs (PAS) Pto regimen (alternative medicines in brackets).
The course of treatment is generally 24 months. For patients with severe disease or comorbidities that affect prognosis, the course of treatment may be extended appropriately. For special patients, such as children, the elderly, pregnant women, those on immunosuppression drugs, and those with adverse drug reactions, doctors can adjust the drug dose or drug based on the above program.
10 Diagnosis andTreatment ofSpecial Anal Fistula
217
10.4.4.2 Surgical Therapy
After regular anti-tuberculosis treatment, after reviewing tuberculosis, the patient should then be treated with surgery. By this time, the surgical treatment is the same as that for common anal stula.
10.4.4.3 Topical Treatment
For postoperative tuberculous anal stula, rifam­picin and some topical anti-tuberculosis drugs can be used at the same time as systemic anti­tuberculosis treatment.

10.5 AIDS Associated with Anal Fistula

Acquired immunodeciency syndrome (AIDS) is a sexually transmitted disease (STD) caused by human immunodeciency virus (HIV) infection and characterized by severe immunodeciency. Patients often contract lymphadenopathy, anorexia, chronic diarrhea, weight loss, fever, fatigue, and other systemic symptoms, and opportunistic infections or secondary tumors can gradually develop and ultimately lead to death. In recent years, the number of patients with AIDS complicated with anorectal diseases has gradu­ally increased. According to the survey, the inci­dence of anorectal diseases in AIDS patients is
92.7% (204/220), including 179 cases of acne
(87.7%) and 15 cases of perianal eczema (7.4%)—18 cases of anal papilloma (accounting for 8.8%), 5 cases of anal condyloma acuminata (2.5%), 3 cases of perianal folliculitis (1.5%), 4 cases of anal ssure (2.0%), and 6 cases of anal stula (2.9%). Some patients had two or more anorectal diseases. There was no signicant cor­relation between the incidence of anorectal dis­eases in AIDS patients and gender, age, ethnicity, drug use, and CD4+ T cell count. It indicates that the incidence of anorectal diseases in AIDS patients is high and the diseases are diverse. Therefore, AIDS patients should pay attention to regular anorectal examinations for early diagno­sis and treatment of anorectal diseases.

10.5.1 Diagnosis

Regular anorectal disease screening is important for AIDS patients, especially gay men. Moreover, the screening method for anorectal diseases is more convenient. More than 90% of anorectal diseases can be found through anal examination, anal nger examination, and anal microscopy. The method is simple, and the patient spends less, and it is easy to be clinically popularized. During the AIDS treatment, clinicians should strengthen the regular screening of patients with anorectal diseases, so that early anorectal dis­eases, early diagnosis, early intervention, and treatment can be found to improve the quality of life of patients.
Anorectal surgeons should consider the pos­sibility of HIV infection for severe, long-term treatment, recurrent episodes of hemorrhoids, perianal eczema, anal condyloma acuminata, perianal folliculitis, anal ssure and anal stula, or anorectal symptoms in high-risk groups. It is necessary to screen all patients with anal stula for HIV before surgery. If HIV infection is sus­pected, a further examination should be carried out and reported to the local CDC.

10.5.2 Treatment

In the AIDS Prevention and Control Regulations, China stipulates that medical institutions may not refrain or refuse treatment of other diseases of AIDS patients. In recent years, the number of HIV/AIDS patients requiring surgery has increased, and hospitals have encountered such patients, but most hospital surgeons will shut out such patients or push them to the so-called “spe­cialized hospitals,” but some specialized hospi­tals do not have the conditions to carry out certain operations of this disease.
HIV/AIDS is not an absolute contraindication to surgery, and reasonable surgical treatment is the only effective way to save some HIV/AIDS patients. Medical staff should take a positive atti­tude toward the operation of HIV/AIDS patients and conduct a comprehensive assessment and